Pain and Sensory Changes Assessment in HIV+ Patients
Source: ClinicalTrials.gov NCT00422695 ↗Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Chronic Myogenic Pain, TMJ Disoder, and Burning Mouth Syndrome |
72; 8; 37; 7; 20; 0 | — |
| PRIMARY Spontaneous Pain Intensity |
2.13; 0.05; 3.69; 0.92 | <0.05 sig |
Eligibility Criteria
Inclusion Criteria
Group I n = 40 HIV+ with CD4+T cells/mm³ > 500 as determined by previous routine medical examination and from previous blood reports.
Group II n = 40 HIV+ with CD4+T cells/mm³ 200-499 as determined by previous routine medical examination and from previous blood reports.
Group III n = 40 HIV+ with CD4+T cells/mm³ < 200 as determined by previous routine medical examination and from previous blood reports.
Control Group n = 40 Healthy with normal blood reports, without dental pathologies.
Exclusion Criteria
- Patients under 18 year of age.
- Pregnant women.
Data sourced from ClinicalTrials.gov (NCT00422695). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.